Psoriasis is a chronic non-infectious disease of a multifactorial nature, which often occurs in the form of rashes and peeling of the skin. Psoriasis occupies a significant share in the dermatological structure of diseases at the present time. [1, 2]. Despite the numerous scientific studies conducted by scientists in many countries regarding the etiology, pathogenesis, clinic and treatment of psoriasis, there is still a question about the main cause of the disease.In a significant number of patients with psoriasis, lesions of the nervous system, cardiovascular, gastrointestinal pathology, pathology of the genitourinary system, as well as, often with damage to the articular systems of the skeleton together with disorders of the immune system, were revealed. All this indicates the multifactorial nature of the disease. In this regard, the search for optimal drugs that would affect several pathogenetic links of the disease is currently underway. [3, 4,]. Therefore, today, we consider this issue relevant.

Psoriasis, chronic, disease non-infectious disease, antioxidant therapy, drugs

Kubanova A. A., Kubanov A. A., Melekhina L. E., Bogdanova E. V. Dermatovenereology in the Russian Federation. Results of 2014 Successes, achievements. The main ways of development // Bulletin of Dermatology and Venereology. 2015. No. 4. P. 109–115.

Bakulev A.L Strategy "treatment to achieve the goal" in psoriasis. Topical issues of resistance to biological therapy // Bulletin of Dermatology and Venereology. 2016; 5: 32-38.

Pearl Y.N., Tereshchenko A.V., GlazkovaY.P., Vikha G.V. Evaluation of the effectiveness and tolerability of immunosuppressive therapy in the complex treatment of psoriasis // Clinical Dermatology and Venereology.-2010.-No.4.

Romantsov M.G., Sukhanov D.S., Petrov A.Y., Alexandrova L.N., Sologub T.V., Kovalenko A.L., Savateeva-Lyubimova T.N., Emelyanova O.Y., Bizenkova M.N. The use of substrates of energy metabolism in chronic liver damage to correct metabolic disorders (experimental and clinical studies). Basic research. 2011; 3: 131-142.

Stelmakh V.V., Kozlov V.K., Radchenko V.G., Nekrasova A.S. Pathogenetic therapy of metabolic syndrome at the stage of organ damage. Clinical medicine. 2012; 6: 61-65.

KharakhordinYu.E., Kharakhordin O.E. Prospects for the use of bacteriorhodopsin in the form of liposomes in the complex therapy of widespread psoriasis: Sat. scientific works. Interdisciplinary scientific and practical. conf. "New methods of diagnosis and treatment of skin diseases and sexually transmitted infections" / scientific. ed. d.m.s. R.M. Abdrakhmanov. March 26, 2009. Kazan

Grishkova ES, Shnyra A. The use of bacteriorhodopsin as a cosmetic and / or therapeutic agent in the complex treatment of dermatoses. - 2017. - No. 3-12. - from. 208-211;

Tolmacheva NV, Anisimova AS Modern view of the etiology and pathogenesis of psoriasis // fundamental research. - 2015. - No. 1-10. - from. 2118-2121;